Page 1 of 2
Page 1 of 2
The global oncology information systems market size was valued at $3,082.3 Million in 2020, and is estimated to reach $5,538.66 Million by 2030, growing at a CAGR of 6% from 2021 to ...
The global nanomedicine market size was valued at $171,695.33 million in 2020, and is projected to reach $393,046.52 million by 2030, registering a CAGR of 9.2% from 2021 to 2030. Nanomedicine is ...
The global stem cell banking market size was valued at $4,298.5 million in 2020, and is projected to reach $16,558.4 million by 2030, registering a CAGR of 15.6% from 2021 to 2030. ...
The global rapid tests market size was valued at $33,329.15 million in 2020, and is projected to reach $97,606.33 million by 2030, registering a CAGR of 11.3% from 2021 to 2030. Rapid ...
The global veterinary oncology market size was valued at $297.30 million in 2020, and is estimated to reach $819.84 million by 2030, growing at a CAGR of 10.8% from 2021 to 2030.
The clinical trial imaging services market accounted for $1,310 million in 2019, and is expected to reach $1,807.65 million by 2027, registering a CAGR of 5.6% from 2020 to 2027.
The global closed system transfer devices market size was valued at $823.58 million in 2020, and is projected to reach $3,271.74 million by 2030, registering a CAGR of 15.4% from 2021 to ...
The global esoteric testing market size was valued at $20,218.60 million in 2020, and is estimated to reach $66,214.79 million by 2030, growing at a CAGR of 12.5% from 2021 to 2030.
Superdisintegrants is the combination of substances which added to the drug formulation that facilitates the disintegration of tablet or capsule content into smaller particles. It consists of fragments of disintegrated parts of ...
Veterinary MRI is the system of imaging that is a common tool for the visualization of the nervous system. It is currently considered to be an ideal method for the imaging the ...
Biologics are genetically engineered proteins which are originated from genes of human. Biologic drugs target the specific parts of the human immune system. Biologics are completely different from chemically synthesized drugs. There ...
Multiplexed diagnostics are used for biological sample examination and to complete a screening process in a single run. Multiplexed diagnostic tests are used to detect and diagnose a variety of diseases and infections, including cancer, allergies, autoimmune diseases, and cardiovascular diseases.
The global cell separation technologies market size was valued at $8,639.20 million in 2019 and is projected to reach $28,766.14 million by 2027, registering a CAGR of 15.4% from 2020 to 2027.
Global Nuclear Medicine Market is expected to garner $8,207.5 million by 2022. The market is currently in its growth stage driven by increasing number of cancer cases and rising awareness about nuclear ...
The Asia-Pacific nuclear medicine market size was valued at $4,116.43 million in 2020, and is projected to reach $8,957.89 million by 2028, registering a CAGR of 10.4% from 2021 to 2028.
The Precision Medicine Market was valued at $3,516 million in 2016, and is estimated to reach at $7,746 million by 2023, registering a CAGR of 11.9% from 2017 to 2023. Precision medicine ...
The global interventional oncology market size was valued at $1,984.00 Million in 2021 and is projected to reach $4,127.21 Million by 2031, registering a CAGR of 7.6% from 2022 to 2031.
The global companion diagnostics market generated $1,678 million in 2018, and is projected to reach $6,452 million by 2026, growing at a CAGR of 18.3% from 2019 to 2026.
The global endoscope + radiofrequency ablation (RFA) market was valued at $3,567 million in 2017 and is estimated to reach at $7,471 million by 2025, registering a CAGR of 9.6% from 2018 ...
The China oncology drugs market was valued at $6,498.2 million in 2018 and is projected to reach $12,688.7 million by 2026, registering a CAGR of 8.7% from 2019 to 2026. Cancer is ...
The Japan oncology drugs market size was accounted for $9,405 million in 2018, and is expected to reach $14,109 million by 2026, registering a CAGR of 5.2% from 2019 to 2026.
The global top 10 cancer drugs market sales was valued at $63,619 million in 2018 and is expected to reach $129,948 million by 2026, registering a CAGR of 9.8% from 2019 to 2026.
The global immuno-oncology assay market accounted for $2,769 million in 2018, and is expected to reach $ 6,179 million by 2026, growing at a CAGR of 10.6% from 2019 to 2026.
The Asia-Pacific oncology molecular diagnostics market was valued at $610.17 Million in 2021, and is projected to reach $1,241.00 Million by 2031, registering a CAGR of 7.3% from 2022 to 2031. Oncology ...
The global specialty PACS market size was valued at $2,682.88 million in 2020, and is projected to reach $4,485.96 million by 2030, registering a CAGR of 5.5% from 2021 to 2030. Picture ...
Page 1 of 2
There might be something that we haven’t covered in the scope and if it is as per your specific areas of interest, we can anytime customise and incorporate your requirements in the framework of the study and provide you with a customised report based on your exact needs.
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers